AAV9-dominant-negative SUN1 miniprotein

AAV9-dominant-negative SUN1 miniprotein has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 5, 2021: “Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy”.

Intervention

1 paper studies it2 findingsUpdated

See all 1 papers on AAV9-dominant-negative SUN1 miniprotein

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Institute of Molecular and Cell Biology and 1 more
  • 2 of 2 findings with company ties
  • Animals1

What did studies of AAV9-dominant-negative SUN1 miniprotein find?

2

Studies of AAV9-dominant-negative SUN1 miniprotein measured 2 outcomes: dilated cardiomyopathy and lifespan.

Dilated cardiomyopathy

downin mice1

1 study
  1. AAV9-dominant-negative SUN1 miniprotein prevents dilated cardiomyopathy in Lmna mutant mice.

    “Cardiomyocyte-specific expression of the SUN1 miniprotein prevents cardiomyopathy progression”

    Animalsin Lmna mutant mice

    Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy

    Nature communications

More on Dilated cardiomyopathy

Lifespan

upin mice1

1 study
  1. AAV9-dominant-negative SUN1 miniprotein extends lifespan in Lmna deficient cardiomyocytes in mice (at least a fivefold extension in lifespan).

    “displacing the cardiomyocyte KASH complexes from the nuclear periphery, resulting in at least a fivefold extension in lifespan.”

    Animalsin Lmna deficient cardiomyocytes in mice

    Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy

    Nature communications

Latest